The Ministry, he said, discussed the matter with the Domestic Trade and Consumer Affairs Ministry last month.
“Every year, the price of medicines goes up by 10% to 20% and this is normal. That is why for normal medicines, we try to use generic ones,” he told reporters after opening the Second International Conference of Pharmacy and Health Sciences here yesterday.
The three-day conference, with the theme “Integrating Research Innovation, Technology, Practices Towards Sustainable Health”, involved 150 local and foreign participants.
Dr Lee said the price increase in medicines was also influenced by the method used to bring them into the country.
Most of the medicines were imported from the United States and Europe, he said.
He said a study conducted in the United States on 13 pharmaceutical companies found that the price increase in medicines was due to advertisement and marketing costs, instead of research and development.
Note: Meanwhile it is observed that the 3 main Pharmaceutical Associations (namely Pharmaceutical Association of Malaysia (PhAMA), Malaysian Organisation of Pharmaceutical Industries (MOPI) and Malaysian Association of Pharmaceutical Suppliers (MAPS) are not being currently engaged by the Ministry of Health in the said formulation of the pricing mechanism that is to be announced.
/Bernama 11-09-2018
Disclaimer: Views or opinions expressed are solely those of the Author and should be used with discretion. The Author shall not be held liable for any acts or omissions arising from the use of the information. The user will be personally liable for any damages or other liability arising hereof.
Post a Comment